Spotlight - Challenges for the Heart Team I - A new interventional paradigm for aortic valve disease

Supported by an unrestricted educational grant from Edwards Lifesciences

Chairpersons: S. Kodali, D. Tchetche

Panellists: V. Bapat, J. Bax, H. Eltchaninoff, M. Lee

Summary

Consult this session on aortic valve disease to learn more about the impact of the latest evidence concerning TAVI vs. SAVR on Heart Team discussions and patient choice (clinical and anatomical characteristics, redistribution of resources and training...), and discover how you and your colleagues can apply this information in daily clinical practice.

Learning Objectives

To appreciate the impact of the latest evidence concerning TAVI vs. SAVR on Heart Team discussions and patient choice
To consider unresolved questions and the implications for future planning and resource allocation
To understand how you and your colleagues can apply this information in daily clinical practice

Presentations available when logged in:

Challenge 1: clinical and anatomical characteristics (rather than surgical risk estimation) now drive the choice between TAVI and SAVR
Challenge 2: redistribution of resources and training are rapidly required to deliver the workload

Your free My PCR account will enable you to:

Become a PCR Companion
Access slide presentations from PCR Courses
Watch session videos and LIVE cases
Discuss cases with your peers
Submit and register for PCR Courses
Register for and view PCR Webinars
Read a selection of articles in EuroIntervention
And more…

Spotlight - Challenges for the Heart Team I - A new interventional paradigm for aortic valve disease

Supported by an unrestricted educational grant from Edwards Lifesciences

Learning Objectives

Log in or create account for free